Tissue Distribution and Phenotype of Human Mast Cells in BRGSF and NSG-SGM3-IL15 Humanized Mice

Worrall WPM
University of Toulouse
September 19, 2025
Allergy
https://pubmed.ncbi.nlm.nih.gov/40974102/

This article is currently being updated. View its version on PubMed.

https://pubmed.ncbi.nlm.nih.gov/40974102/

Research summary

This study evaluated human mast cell (hMC) development, distribution, and activation in CD34⁺ HSC-engrafted humanized mouse models. BRGSF mice supported hMC presence in skin, lung, and gut. hMCs expressed key markers including KIT, FcεRI, and MRGPRX2. Functional activity was confirmed via passive cutaneous anaphylaxis assay. Single-cell transcriptomics showed phenotypic diversity of engrafted hMCs.

Key outcome of the study

BRGSF mice supported engraftment of functionally mature human mast cells in multiple tissues. hMCs showed appropriate surface marker expression and transcriptional heterogeneity, enabling in vivo study of mast cell biology and allergic responses.

Model

Immunodeficient humanized mouse strain (BRGSF) engrafted with human CD34⁺ hematopoietic stem cells

TARGET:
Not applicable
Synonyms:
Not applicable

Keywords

Human mast cell biology, allergy modeling, in vivo humanized immune models, passive anaphylaxis assays, mast cell engraftment

Technical specifications

Humanized mouse engraftment of CD34⁺ progenitors, flow cytometry of hCD45⁺ populations, immunofluorescence tissue imaging, single-cell RNA sequencing (skin, gut), passive cutaneous anaphylaxis assay, serum tryptase quantification

Related products

Catalogue product

genO‑BRGSF‑HIS

genO‑BRGSF‑HIS mice possess the most functional reconstituted human immune system currently on the market and are highly relevant for translational research.

Customized product

No items found.

Catalogue product

No items found.
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe